<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37858176</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms.</ArticleTitle><Pagination><StartPage>75</StartPage><MedlinePgn>75</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">75</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-023-00665-w</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by the loss of both upper and lower motor neurons, resulting in muscle weakness, atrophy, paralysis, and eventually death. Motor cortical hyperexcitability is a common phenomenon observed at the presymptomatic stage of ALS. Both cell-autonomous (the intrinsic properties of motor neurons) and non-cell-autonomous mechanisms (cells other than motor neurons) are believed to contribute to cortical hyperexcitability. Decoding the pathological relevance of these dynamic changes in motor neurons and glial cells has remained a major challenge. This review summarizes the evidence of cortical hyperexcitability from both clinical and preclinical research, as well as the underlying mechanisms. We discuss the potential role of glial cells, particularly microglia, in regulating abnormal neuronal activity during the disease progression. Identifying early changes such as neuronal hyperexcitability in the motor system may provide new insights for earlier diagnosis of ALS and reveal novel targets to halt the disease progression.</AbstractText><CopyrightInformation>&#xa9; 2023. Editorial Group and BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Manling</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pallegar</LastName><ForeName>Praveen N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parusel</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Aivi T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Long-Jun</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0001-8019-3380</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. wu.longjun@mayo.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. wu.longjun@mayo.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Rochester, MN, USA. wu.longjun@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35NS132326</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1AG082314</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19AG 069701</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>0</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37858176</ArticleId><ArticleId IdType="pmc">PMC10585818</ArticleId><ArticleId IdType="doi">10.1186/s13024-023-00665-w</ArticleId><ArticleId IdType="pii">10.1186/s13024-023-00665-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goetz CG. Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot. Muscle Nerve. 2000;23:336&#x2013;343. doi: 10.1002/(SICI)1097-4598(200003)23:3&lt;336::AID-MUS4&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(200003)23:3&lt;336::AID-MUS4&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">10679709</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, de Visser M, Veldink JH, van den Berg LH. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165&#x2013;1170. doi: 10.1136/jnnp.2011.244939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2011.244939</ArticleId><ArticleId IdType="pubmed">21622937</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E. Eurals: Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittie M, Nelson LM, Usher S, Ward K, Benatar M. Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment. Neuroepidemiology. 2013;40:133&#x2013;141. doi: 10.1159/000342156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000342156</ArticleId><ArticleId IdType="pubmed">23095852</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Raymond J, Punjani R, Han M, Larson T, Kaye W, Nelson LM, Topol B, Muravov O, Genson C, Horton DK. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies. Amyotroph Lateral Scler Frontotemporal Degener. 2017;2022:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9568617</ArticleId><ArticleId IdType="pubmed">35422180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Raymond J, Punjani R, Larson T, Bove F, Kaye W, Nelson LM, Topol B, Han M, Muravov O, et al. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:220&#x2013;225. doi: 10.1080/21678421.2021.1949021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1949021</ArticleId><ArticleId IdType="pubmed">34423697</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Mehal JM, Holman RC, Rowland LP, Rowland AS, Cheek JE. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives. JAMA Neurol. 2013;70:476&#x2013;480. doi: 10.1001/jamaneurol.2013.929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.929</ArticleId><ArticleId IdType="pubmed">23440294</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30&#x2013;32. doi: 10.1136/jnnp.2007.117788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.117788</ArticleId><ArticleId IdType="pubmed">17634215</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Zhou Y, Qian S, Chang W, Wang L, Fan D. Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015. Brain Behav. 2018;8:e01131. doi: 10.1002/brb3.1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1131</ArticleId><ArticleId IdType="pmc">PMC6236245</ArticleId><ArticleId IdType="pubmed">30338660</ArticleId></ArticleIdList></Reference><Reference><Citation>Palese F, Sartori A, Verriello L, Ros S, Passadore P, Manganotti P, Barbone F, Pisa FE. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002&#x2013;2014: a retrospective population-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:90&#x2013;99. doi: 10.1080/21678421.2018.1511732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1511732</ArticleId><ArticleId IdType="pubmed">30430867</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjaminsen E, Alstadhaug KB, Gulsvik M, Baloch FK, Odeh F. Amyotrophic lateral sclerosis in Nordland county, Norway, 2000&#x2013;2015: prevalence, incidence, and clinical features. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:522&#x2013;527. doi: 10.1080/21678421.2018.1513534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1513534</ArticleId><ArticleId IdType="pubmed">30265157</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology. 1986;36:511&#x2013;517. doi: 10.1212/WNL.36.4.511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.36.4.511</ArticleId><ArticleId IdType="pubmed">3960325</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A. The dying forward hypothesis of ALS: tracing its history. Brain Sci. 2021;11(3):300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997258</ArticleId><ArticleId IdType="pubmed">33673524</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker MR. ALS&#x2013;dying forward, backward or outward? Nat Rev Neurol. 2014;10:660. doi: 10.1038/nrneurol.2013.221-c1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221-c1</ArticleId><ArticleId IdType="pmc">PMC4221249</ArticleId><ArticleId IdType="pubmed">25245152</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar M, Viden A, Cuic B, Wang T, Rosier M, Tomas D, Mills SA, Govier-Cole A, Djouma E, Luikinga S, et al: Cortical hyperexcitability drives dying forward ALS symptoms and pathology in mice. bioRxiv 2021:2021.2008.2013.456320.</Citation></Reference><Reference><Citation>Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131:1540&#x2013;1550. doi: 10.1093/brain/awn071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn071</ArticleId><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129:2436&#x2013;2446. doi: 10.1093/brain/awl172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl172</ArticleId><ArticleId IdType="pubmed">16835248</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SS, Sandoe J, Perez NP, Williams LA, Lee S, Boulting G, et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7:1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Kiernan MC, Vucic S. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin Neurophysiol. 2015;126:803&#x2013;809. doi: 10.1016/j.clinph.2014.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.04.023</ArticleId><ArticleId IdType="pubmed">25227219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankisi H, Nielsen CS, Howells J, Cengiz B, Samusyte G, Koltzenburg M, Blicher JU, Moller AT, Pugdahl K, Fuglsang-Frederiksen A, et al. Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation. Eur J Neurol. 2021;28:3030&#x2013;3039. doi: 10.1111/ene.15010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15010</ArticleId><ArticleId IdType="pmc">PMC9291110</ArticleId><ArticleId IdType="pubmed">34233060</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Noakes PG, Bellingham MC. Motor cortex layer V pyramidal neurons exhibit dendritic regression, spine loss, and increased synaptic excitation in the presymptomatic hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Neurosci. 2015;35:643&#x2013;647. doi: 10.1523/JNEUROSCI.3483-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3483-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605367</ArticleId><ArticleId IdType="pubmed">25589758</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Hughes EG, Shetty AS, Arlotta P, Goff LA, Bergles DE, Brown SP. Changes in the Excitability of Neocortical Neurons in a Mouse Model of Amyotrophic Lateral Sclerosis Are Not Specific to Corticospinal Neurons and Are Modulated by Advancing Disease. J Neurosci. 2017;37:9037&#x2013;9053. doi: 10.1523/JNEUROSCI.0811-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0811-17.2017</ArticleId><ArticleId IdType="pmc">PMC5597984</ArticleId><ArticleId IdType="pubmed">28821643</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Silva ML, Imhoff-Manuel RD, Sharma A, Heckman CJ, Shneider NA, Roselli F, Zytnicki D, Manuel M. Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS. Elife. 2018;7:e30955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5922970</ArticleId><ArticleId IdType="pubmed">29580378</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A, Ning K, Heath PR, Wood E, Kirby J, Fusi N, Lawrence N, Wharton SB, Ince PG, Shaw PJ. Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol. 2013;125:95&#x2013;109. doi: 10.1007/s00401-012-1058-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1058-5</ArticleId><ArticleId IdType="pmc">PMC3535376</ArticleId><ArticleId IdType="pubmed">23143228</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Sheets PL, Nigro MJ, Peric M, Brooks C, Heller DB, Martina M, Andjus PR, Ozdinler PH. The electrophysiological determinants of corticospinal motor neuron vulnerability in ALS. Front Mol Neurosci. 2020;13:73. doi: 10.3389/fnmol.2020.00073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00073</ArticleId><ArticleId IdType="pmc">PMC7248374</ArticleId><ArticleId IdType="pubmed">32508590</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunes ZI, Kan VWY, Ye X, Liebscher S. Exciting complexity: the role of motor circuit elements in ALS pathophysiology. Front Neurosci. 2020;14:573. doi: 10.3389/fnins.2020.00573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00573</ArticleId><ArticleId IdType="pmc">PMC7311855</ArticleId><ArticleId IdType="pubmed">32625051</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Castaneda R, Zingg B, Matho KS, Chen X, Wang Q, Foster NN, Li A, Narasimhan A, Hirokawa KE, Huo B, et al. Cellular anatomy of the mouse primary motor cortex. Nature. 2021;598:159&#x2013;166. doi: 10.1038/s41586-021-03970-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03970-w</ArticleId><ArticleId IdType="pmc">PMC8494646</ArticleId><ArticleId IdType="pubmed">34616071</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, Ozdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol. 2016;12:651&#x2013;661. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Itoyama Y, Sobue G, Tsuji S, Aoki M, Doyu M, Hamada C, Kondo K, Yoneoka T, Akimoto M, et al. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:610&#x2013;617. doi: 10.3109/21678421.2014.959024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959024</ArticleId><ArticleId IdType="pmc">PMC4266079</ArticleId><ArticleId IdType="pubmed">25286015</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JH, Huang CS, Nagata K, Yeh JZ, Narahashi T. Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther. 1997;282:707&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">9262334</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellingham MC. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther. 2011;17:4&#x2013;31. doi: 10.1111/j.1755-5949.2009.00116.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-5949.2009.00116.x</ArticleId><ArticleId IdType="pmc">PMC6493865</ArticleId><ArticleId IdType="pubmed">20236142</ArticleId></ArticleIdList></Reference><Reference><Citation>Debono MW, Le Guern J, Canton T, Doble A, Pradier L. Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur J Pharmacol. 1993;235:283&#x2013;289. doi: 10.1016/0014-2999(93)90147-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(93)90147-A</ArticleId><ArticleId IdType="pubmed">7685290</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieve SM, Menon P, Korgaonkar MS, Gomes L, Foster S, Kiernan MC, Vucic S. Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17:85&#x2013;92. doi: 10.3109/21678421.2015.1074707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1074707</ArticleId><ArticleId IdType="pubmed">26458122</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Van den Bos M, Menon P, Vucic S. Utility of transcranial magnetic simulation in studying upper motor neuron dysfunction in amyotrophic lateral sclerosis. Brain Sci. 2021;11(7):906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8304017</ArticleId><ArticleId IdType="pubmed">34356140</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RA, Agosta F, Grosskreutz J, Filippi M, Turner MR. Neuroimaging endpoints in amyotrophic lateral sclerosis. Neurotherapeutics. 2017;14:11&#x2013;23. doi: 10.1007/s13311-016-0484-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0484-9</ArticleId><ArticleId IdType="pmc">PMC5233627</ArticleId><ArticleId IdType="pubmed">27752938</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S. Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques. Int J Mol Sci. 2019;20(11):2818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6600525</ArticleId><ArticleId IdType="pubmed">31185581</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Pavey N, Haidar M, Turner BJ, Kiernan MC. Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS. Neurosci Lett. 2021;759:136039. doi: 10.1016/j.neulet.2021.136039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2021.136039</ArticleId><ArticleId IdType="pubmed">34118310</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, Di Lazzaro V, Ferreri F, Fitzgerald PB, George MS, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015;126:1071&#x2013;1107. doi: 10.1016/j.clinph.2015.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2015.02.001</ArticleId><ArticleId IdType="pmc">PMC6350257</ArticleId><ArticleId IdType="pubmed">25797650</ArticleId></ArticleIdList></Reference><Reference><Citation>Klomjai W, Katz R, Lackmy-Vallee A. Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS) Ann Phys Rehabil Med. 2015;58:208&#x2013;213. doi: 10.1016/j.rehab.2015.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rehab.2015.05.005</ArticleId><ArticleId IdType="pubmed">26319963</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez V. The Use of Motor-Evoked Potentials in Clinical Trials in Multiple Sclerosis. J Clin Neurophysiol. 2021;38:166&#x2013;170. doi: 10.1097/WNP.0000000000000734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNP.0000000000000734</ArticleId><ArticleId IdType="pubmed">33958566</ArticleId></ArticleIdList></Reference><Reference><Citation>Udupa K, Chen R. Central motor conduction time. Handb Clin Neurol. 2013;116:375&#x2013;386. doi: 10.1016/B978-0-444-53497-2.00031-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-53497-2.00031-0</ArticleId><ArticleId IdType="pubmed">24112910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeugin D, Ionta S. Anatomo-Functional Origins of the Cortical Silent Period: Spotlight on the Basal Ganglia. Brain Sci. 2021;11(6):705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8227635</ArticleId><ArticleId IdType="pubmed">34071742</ArticleId></ArticleIdList></Reference><Reference><Citation>Samusyte G, Bostock H, Rothwell J, Koltzenburg M. Short-interval intracortical inhibition: Comparison between conventional and threshold-tracking techniques. Brain Stimul. 2018;11:806&#x2013;817. doi: 10.1016/j.brs.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC6028741</ArticleId><ArticleId IdType="pubmed">29573989</ArticleId></ArticleIdList></Reference><Reference><Citation>Mello EA, Cohen LG, Monteiro Dos Anjos S, Conti J, Andrade KN, Tovar Moll F, Marins T, Fernandes CA, Rodrigues W, Jr, Conforto AB. Increase in short-interval intracortical facilitation of the motor cortex after low-frequency repetitive magnetic stimulation of the unaffected hemisphere in the subacute phase after stroke. Neural Plast. 2015;2015:407320. doi: 10.1155/2015/407320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/407320</ArticleId><ArticleId IdType="pmc">PMC4427769</ArticleId><ArticleId IdType="pubmed">26060584</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Filippini N, Knight S, Talbot K, Turner MR. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain. 2011;134:3470&#x2013;3479. doi: 10.1093/brain/awr279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr279</ArticleId><ArticleId IdType="pubmed">22075069</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt R, Verstraete E, de Reus MA, Veldink JH, van den Berg LH, van den Heuvel MP. Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis. Hum Brain Mapp. 2014;35:4386&#x2013;4395. doi: 10.1002/hbm.22481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.22481</ArticleId><ArticleId IdType="pmc">PMC4207190</ArticleId><ArticleId IdType="pubmed">24604691</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer PM, Egan C, Pinto-Grau M, Burke T, Elamin M, Nasseroleslami B, Pender N, Lalor EC, Hardiman O. Functional connectivity changes in resting-state EEG as potential biomarker for amyotrophic lateral sclerosis. PLoS ONE. 2015;10:e0128682. doi: 10.1371/journal.pone.0128682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128682</ArticleId><ArticleId IdType="pmc">PMC4474889</ArticleId><ArticleId IdType="pubmed">26091258</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot M, Rohenkohl G, Quinn A, Colclough GL, Wuu J, Talbot K, Woolrich MW, Benatar M, Nobre AC, Turner MR. Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis. Hum Brain Mapp. 2017;38:237&#x2013;254. doi: 10.1002/hbm.23357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23357</ArticleId><ArticleId IdType="pmc">PMC5215611</ArticleId><ArticleId IdType="pubmed">27623516</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot M, Colclough GL, Quinn A, Wuu J, Talbot K, Benatar M, Nobre AC, Woolrich MW, Turner MR. Increased cerebral functional connectivity in ALS: A resting-state magnetoencephalography study. Neurology. 2018;90:e1418&#x2013;e1424. doi: 10.1212/WNL.0000000000005333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005333</ArticleId><ArticleId IdType="pmc">PMC5902786</ArticleId><ArticleId IdType="pubmed">29661904</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E, Baas F, Iyer A, ten Asbroek AL, Morello G, Cavallaro S. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol Dis. 2015;74:359&#x2013;376. doi: 10.1016/j.nbd.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaitakis A, Constantakakis E. Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis. Brain Res Bull. 1993;30:381&#x2013;386. doi: 10.1016/0361-9230(93)90269-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0361-9230(93)90269-H</ArticleId><ArticleId IdType="pubmed">8457887</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Petropoulou O, Zis V, Sfagos C, Vassilopoulos D. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis. In Vivo. 2008;22:137&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">18396796</ArticleId></ArticleIdList></Reference><Reference><Citation>Foran E, Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal. 2009;11:1587&#x2013;1602. doi: 10.1089/ars.2009.2444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2444</ArticleId><ArticleId IdType="pmc">PMC2842587</ArticleId><ArticleId IdType="pubmed">19413484</ArticleId></ArticleIdList></Reference><Reference><Citation>Khademullah CS, Aqrabawi AJ, Place KM, Dargaei Z, Liang X, Pressey JC, Bedard S, Yang JW, Garand D, Keramidis I, et al. Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis. Brain. 2020;143:800&#x2013;810. doi: 10.1093/brain/awaa034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa034</ArticleId><ArticleId IdType="pubmed">32203578</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S, Krampfl K, Hashemi F, Grothe C, Hori A, Dengler R, Bufler J. Distribution of GABAA receptor mRNA in the motor cortex of ALS patients. J Neuropathol Exp Neurol. 2003;62:1041&#x2013;1051. doi: 10.1093/jnen/62.10.1041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/62.10.1041</ArticleId><ArticleId IdType="pubmed">14575239</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Callaghan BC, Petrou M, Edden RA, Chenevert TL, Feldman EL. Decreased motor cortex gamma-aminobutyric acid in amyotrophic lateral sclerosis. Neurology. 2012;78:1596&#x2013;1600. doi: 10.1212/WNL.0b013e3182563b57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182563b57</ArticleId><ArticleId IdType="pmc">PMC3348851</ArticleId><ArticleId IdType="pubmed">22517106</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Pomper MG, Callaghan BC, Petrou M, Edden RA, Mohamed MA, Welsh RC, Carlos RC, Barker PB, Feldman EL. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol. 2013;70:1009&#x2013;1016. doi: 10.1001/jamaneurol.2013.234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.234</ArticleId><ArticleId IdType="pmc">PMC4382938</ArticleId><ArticleId IdType="pubmed">23797905</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, Tripathy K, Kwong LK, Trojanowski JQ, Lee VM. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130:643&#x2013;660. doi: 10.1007/s00401-015-1460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick-de Groote C, Van Broeckhoven C, Kumar-Singh S. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2010;107:3858&#x2013;3863. doi: 10.1073/pnas.0912417107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912417107</ArticleId><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieri M, Albo F, Gaetti C, Spalloni A, Bengtson CP, Longone P, Cavalcanti S, Zona C. Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett. 2003;351:153&#x2013;156. doi: 10.1016/j.neulet.2003.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2003.07.010</ArticleId><ArticleId IdType="pubmed">14623129</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Klenowski PM, Lee JD, Drieberg-Thompson JR, Bartlett SE, Ngo ST, Hilliard MA, Bellingham MC, Noakes PG. Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis. Sci Rep. 2016;6:37968. doi: 10.1038/srep37968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep37968</ArticleId><ArticleId IdType="pmc">PMC5126629</ArticleId><ArticleId IdType="pubmed">27897242</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TW, Wardill TJ, Sun Y, Pulver SR, Renninger SL, Baohan A, Schreiter ER, Kerr RA, Orger MB, Jayaraman V, et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature. 2013;499:295&#x2013;300. doi: 10.1038/nature12354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12354</ArticleId><ArticleId IdType="pmc">PMC3777791</ArticleId><ArticleId IdType="pubmed">23868258</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres-Benito P, Moreno J, Aso E, Povedano M, Ferrer I. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration. Aging (Albany NY) 2017;9:823&#x2013;851. doi: 10.18632/aging.101195.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101195</ArticleId><ArticleId IdType="pmc">PMC5391234</ArticleId><ArticleId IdType="pubmed">28283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalloni A, Origlia N, Sgobio C, Trabalza A, Nutini M, Berretta N, Bernardi G, Domenici L, Ammassari-Teule M, Longone P. Postsynaptic alteration of NR2A subunit and defective autophosphorylation of alphaCaMKII at threonine-286 contribute to abnormal plasticity and morphology of upper motor neurons in presymptomatic SOD1G93A mice, a murine model for amyotrophic lateral sclerosis. Cereb Cortex. 2011;21:796&#x2013;805. doi: 10.1093/cercor/bhq152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhq152</ArticleId><ArticleId IdType="pubmed">20732897</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieri M, Carunchio I, Curcio L, Mercuri NB, Zona C. Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol. 2009;215:368&#x2013;379. doi: 10.1016/j.expneurol.2008.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2008.11.002</ArticleId><ArticleId IdType="pubmed">19071115</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Kiernan MC. Upregulation of persistent sodium conductances in familial ALS. J Neurol Neurosurg Psychiatry. 2010;81:222&#x2013;227. doi: 10.1136/jnnp.2009.183079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183079</ArticleId><ArticleId IdType="pubmed">19726402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, Sawai S, Hattori T, Bostock H. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain. 2006;129:953&#x2013;962. doi: 10.1093/brain/awl024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl024</ArticleId><ArticleId IdType="pubmed">16467388</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K, Misawa S, Arai K, Nakata M, Kanai K, Yoshiyama Y, Ito K, Isose S, Noto Y, Nasu S, et al. Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical study. Exp Neurol. 2011;232:149&#x2013;153. doi: 10.1016/j.expneurol.2011.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.08.015</ArticleId><ArticleId IdType="pubmed">21906595</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang YM, Yamamoto M, Kobayashi Y, Yoshihara T, Liang Y, Terao S, Takeuchi H, Ishigaki S, Katsuno M, Adachi H, et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol. 2005;57:236&#x2013;251. doi: 10.1002/ana.20379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20379</ArticleId><ArticleId IdType="pubmed">15668976</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Hasegawa K, Liu M, Song WJ. Comparison of the Upper Marginal Neurons of Cortical Layer 2 with Layer 2/3 Pyramidal Neurons in Mouse Temporal Cortex. Front Neuroanat. 2017;11:115. doi: 10.3389/fnana.2017.00115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2017.00115</ArticleId><ArticleId IdType="pmc">PMC5742574</ArticleId><ArticleId IdType="pubmed">29311847</ArticleId></ArticleIdList></Reference><Reference><Citation>Commisso B, Ding L, Varadi K, Gorges M, Bayer D, Boeckers TM, Ludolph AC, Kassubek J, Muller OJ, Roselli F. Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9. Elife. 2018;7:e36892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6125125</ArticleId><ArticleId IdType="pubmed">30136928</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X, Li F, Zhou H, Xia XG. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 2013;32:1917&#x2013;1926. doi: 10.1038/emboj.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc Natl Acad Sci U S A. 2002;99:1604&#x2013;1609. doi: 10.1073/pnas.032539299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.032539299</ArticleId><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C, Tortarolo M, Suchak SK, Calvaresi N, Carvelli L, Bastone A, Rizzi M, Rattray M, Mennini T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem. 2001;79:737&#x2013;746. doi: 10.1046/j.1471-4159.2001.00572.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00572.x</ArticleId><ArticleId IdType="pubmed">11723166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Komori T, Iwata M. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol. 2000;100:138&#x2013;144. doi: 10.1007/s004019900159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004019900159</ArticleId><ArticleId IdType="pubmed">10963360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol. 2011;226:2484&#x2013;2493. doi: 10.1002/jcp.22609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22609</ArticleId><ArticleId IdType="pmc">PMC3130100</ArticleId><ArticleId IdType="pubmed">21792905</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler PH, Benn S, Yamamoto TH, Guzel M, Brown RH, Jr, Macklis JD. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G(9)(3)A transgenic ALS mice. J Neurosci. 2011;31:4166&#x2013;4177. doi: 10.1523/JNEUROSCI.4184-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4184-10.2011</ArticleId><ArticleId IdType="pmc">PMC3643523</ArticleId><ArticleId IdType="pubmed">21411657</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RM, Blizzard CA, Young KM, King AE, Dickson TC. Calretinin and Neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1(G93A) mouse model of ALS. Sci Rep. 2017;7:44461. doi: 10.1038/srep44461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44461</ArticleId><ArticleId IdType="pmc">PMC5353592</ArticleId><ArticleId IdType="pubmed">28294153</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Gonzalez JL, Moser J, Lauritzen M, Schmitt-John T, Jensen K. Reduced GABAergic inhibition explains cortical hyperexcitability in the wobbler mouse model of ALS. Cereb Cortex. 2011;21:625&#x2013;635. doi: 10.1093/cercor/bhq134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhq134</ArticleId><ArticleId IdType="pubmed">20643756</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Sanjuan-Ruiz I, Kan V, Megat S, De Rossi P, Dieterle S, Cassel R, Jamet M, Kessler P, Wiesner D, et al. Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects. Nat Commun. 2021;12:3028. doi: 10.1038/s41467-021-23187-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23187-9</ArticleId><ArticleId IdType="pmc">PMC8140148</ArticleId><ArticleId IdType="pubmed">34021132</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762:1068&#x2013;1082. doi: 10.1016/j.bbadis.2006.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.002</ArticleId><ArticleId IdType="pubmed">16806844</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J, Van Den Bosch L, Keller BU. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47:165&#x2013;174. doi: 10.1016/j.ceca.2009.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.12.002</ArticleId><ArticleId IdType="pubmed">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal SS, Gomes CM. Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability. Front Cell Neurosci. 2015;9:225. doi: 10.3389/fncel.2015.00225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00225</ArticleId><ArticleId IdType="pmc">PMC4468822</ArticleId><ArticleId IdType="pubmed">26136661</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Van Den Bosch L, Van Houtte E, Callewaert G, Robberecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J Neurophysiol. 2002;88:1279&#x2013;1287. doi: 10.1152/jn.2002.88.3.1279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.2002.88.3.1279</ArticleId><ArticleId IdType="pubmed">12205149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature. 2004;427:801. doi: 10.1038/427801a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/427801a</ArticleId><ArticleId IdType="pubmed">14985749</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Braeken D, Callewaert G, Robberecht W, Van Den Bosch L. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2005;64:605&#x2013;612. doi: 10.1097/01.jnen.0000171647.09589.07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000171647.09589.07</ArticleId><ArticleId IdType="pubmed">16042312</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation. Mol Cell Ther. 2014;2:26. doi: 10.1186/2052-8426-2-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2052-8426-2-26</ArticleId><ArticleId IdType="pmc">PMC4452055</ArticleId><ArticleId IdType="pubmed">26056593</ArticleId></ArticleIdList></Reference><Reference><Citation>von Lewinski F, Keller BU. Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends Neurosci. 2005;28:494&#x2013;500. doi: 10.1016/j.tins.2005.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2005.07.001</ArticleId><ArticleId IdType="pubmed">16026864</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies FM, Ince PG, Shaw PJ. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int. 2002;40:543&#x2013;551. doi: 10.1016/S0197-0186(01)00125-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-0186(01)00125-5</ArticleId><ArticleId IdType="pubmed">11850111</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal MF. Mitochondria and the pathogenesis of ALS. Brain. 2000;123(Pt 7):1291&#x2013;1292. doi: 10.1093/brain/123.7.1291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/123.7.1291</ArticleId><ArticleId IdType="pubmed">10869044</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S. Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2010;69:346&#x2013;355. doi: 10.1097/NEN.0b013e3181d44992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181d44992</ArticleId><ArticleId IdType="pubmed">20448480</ArticleId></ArticleIdList></Reference><Reference><Citation>Karademir B, Corek C, Ozer NK. Endoplasmic reticulum stress and proteasomal system in amyotrophic lateral sclerosis. Free Radic Biol Med. 2015;88:42&#x2013;50. doi: 10.1016/j.freeradbiomed.2015.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.05.038</ArticleId><ArticleId IdType="pubmed">26073124</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi G, Kawamata H. Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis. Neurobiol Dis. 2016;90:35&#x2013;42. doi: 10.1016/j.nbd.2015.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4754163</ArticleId><ArticleId IdType="pubmed">26282323</ArticleId></ArticleIdList></Reference><Reference><Citation>Roussel BD, Kruppa AJ, Miranda E, Crowther DC, Lomas DA, Marciniak SJ. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 2013;12:105&#x2013;118. doi: 10.1016/S1474-4422(12)70238-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70238-7</ArticleId><ArticleId IdType="pubmed">23237905</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol. 1994;36:846&#x2013;858. doi: 10.1002/ana.410360608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410360608</ArticleId><ArticleId IdType="pubmed">7998770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Warita H, Komori T, Murakami T, Abe K, Iwata M. Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2006;1083:196&#x2013;203. doi: 10.1016/j.brainres.2006.01.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2006.01.129</ArticleId><ArticleId IdType="pubmed">16546142</ArticleId></ArticleIdList></Reference><Reference><Citation>Do-Ha D, Buskila Y, Ooi L. Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy. Mol Neurobiol. 2018;55:1410&#x2013;1418. doi: 10.1007/s12035-017-0392-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0392-y</ArticleId><ArticleId IdType="pubmed">28160214</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunet A, Stuart-Lopez G, Burg T, Scekic-Zahirovic J, Rouaux C. Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis. Front Neurosci. 2020;14:363. doi: 10.3389/fnins.2020.00363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00363</ArticleId><ArticleId IdType="pmc">PMC7201269</ArticleId><ArticleId IdType="pubmed">32410944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HG, Wheeler MA, Quintana FJ. Function and therapeutic value of astrocytes in neurological diseases. Nat Rev Drug Discov. 2022;21:339&#x2013;358. doi: 10.1038/s41573-022-00390-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-022-00390-x</ArticleId><ArticleId IdType="pmc">PMC9081171</ArticleId><ArticleId IdType="pubmed">35173313</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew MV. Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity. Trends Immunol. 2020;41:758&#x2013;770. doi: 10.1016/j.it.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7484257</ArticleId><ArticleId IdType="pubmed">32819810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Harlan BA, Killoy KM, Vargas MR. Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Curr Pharm Des. 2017;23:5010&#x2013;5021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5740017</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Sequeira C, Barbosa M, Cunha C, Vaz AR, Brites D. Astrocyte regional diversity in ALS includes distinct aberrant phenotypes with common and causal pathological processes. Exp Cell Res. 2020;395:112209. doi: 10.1016/j.yexcr.2020.112209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.112209</ArticleId><ArticleId IdType="pubmed">32739211</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K, Huang H, Peterson A, Hu B, Maragakis NJ, Ming GL, Chen H, Zhang SC. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Reports. 2017;8:843&#x2013;855. doi: 10.1016/j.stemcr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadeas ST, Kraig SE, O'Banion C, Lepore AC, Maragakis NJ. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc Natl Acad Sci U S A. 2011;108:17803&#x2013;17808. doi: 10.1073/pnas.1103141108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103141108</ArticleId><ArticleId IdType="pmc">PMC3203804</ArticleId><ArticleId IdType="pubmed">21969586</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci. 2008;11:1294&#x2013;1301. doi: 10.1038/nn.2210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2210</ArticleId><ArticleId IdType="pmc">PMC2656686</ArticleId><ArticleId IdType="pubmed">18931666</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardjan N, Verkhratsky A, Zorec R. Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration. Int J Mol Sci. 2017;18(2):358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5343893</ArticleId><ArticleId IdType="pubmed">28208745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H, Ng SK, Diaz N, Burstein S, Morel L, Osgood A, Sider B, Higashimori H, Haydon PG, Manfredi G, Yang Y. Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J Neurosci. 2014;34:2331&#x2013;2348. doi: 10.1523/JNEUROSCI.2689-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2689-13.2014</ArticleId><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana F, Brambilla L, Valori CF, Bergamaschi C, Roncoroni C, Aronica E, Volterra A, Bezzi P, Rossi D. The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Hum Mol Genet. 2012;21:826&#x2013;840. doi: 10.1093/hmg/ddr513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr513</ArticleId><ArticleId IdType="pubmed">22072391</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A. Astroglial Calcium Signaling in Aging and Alzheimer's Disease. Cold Spring Harb Perspect Biol. 2019;11(7):a035188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6601464</ArticleId><ArticleId IdType="pubmed">31110130</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M, Bonifacino T, Fedele E, Rebosio C, Cattaneo L, Benfenati F, Usai C, Bonanno G. Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. Neurobiol Dis. 2015;74:314&#x2013;324. doi: 10.1016/j.nbd.2014.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.004</ArticleId><ArticleId IdType="pubmed">25497732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience. 2004;129:1045&#x2013;1056. doi: 10.1016/j.neuroscience.2004.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2004.06.008</ArticleId><ArticleId IdType="pmc">PMC2322935</ArticleId><ArticleId IdType="pubmed">15561419</ArticleId></ArticleIdList></Reference><Reference><Citation>Bataveljic D, Nikolic L, Milosevic M, Todorovic N, Andjus PR. Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model. Glia. 2012;60:1991&#x2013;2003. doi: 10.1002/glia.22414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22414</ArticleId><ArticleId IdType="pubmed">22987392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser M, Maletzki I, Hulsmann S, Holtmann B, Schulz-Schaeffer W, Kirchhoff F, Bahr M, Neusch C. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem. 2006;99:900&#x2013;912. doi: 10.1111/j.1471-4159.2006.04131.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.04131.x</ArticleId><ArticleId IdType="pubmed">16925593</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann CN, Devi SS, Kersting CT, Bleem AV, Karch CM, Holtzman DM, Gallardo G. Astrocytic alpha2-Na(+)/K(+) ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model. Sci Transl Med. 2022;14:eabm107. doi: 10.1126/scitranslmed.abm4107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abm4107</ArticleId><ArticleId IdType="pmc">PMC9161722</ArticleId><ArticleId IdType="pubmed">35171651</ArticleId></ArticleIdList></Reference><Reference><Citation>Breslin K, Wade JJ, Wong-Lin K, Harkin J, Flanagan B, Van Zalinge H, Hall S, Walker M, Verkhratsky A, McDaid L. Potassium and sodium microdomains in thin astroglial processes: A computational model study. PLoS Comput Biol. 2018;14:e1006151. doi: 10.1371/journal.pcbi.1006151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1006151</ArticleId><ArticleId IdType="pmc">PMC5979043</ArticleId><ArticleId IdType="pubmed">29775457</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose CR, Ziemens D, Verkhratsky A. On the special role of NCX in astrocytes: Translating Na(+)-transients into intracellular Ca(2+) signals. Cell Calcium. 2020;86:102154. doi: 10.1016/j.ceca.2019.102154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2019.102154</ArticleId><ArticleId IdType="pubmed">31901681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Higginbottom A, Heath PR, Barber S, Greenald D, Kirby J, Shaw PJ. Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011;134:2627&#x2013;2641. doi: 10.1093/brain/awr193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr193</ArticleId><ArticleId IdType="pmc">PMC3170534</ArticleId><ArticleId IdType="pubmed">21908873</ArticleId></ArticleIdList></Reference><Reference><Citation>Madji Hounoum B, Mavel S, Coque E, Patin F, Vourc'h P, Marouillat S, Nadal-Desbarats L, Emond P, Corcia P, Andres CR, et al. Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia. 2017;65:592&#x2013;605. doi: 10.1002/glia.23114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23114</ArticleId><ArticleId IdType="pubmed">28139855</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Dhull DK, Nalini A, Vijayalakshmi K, Sathyaprabha TN, Alladi PA, Raju TR. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J Neuroinflammation. 2016;13:212. doi: 10.1186/s12974-016-0698-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0698-0</ArticleId><ArticleId IdType="pmc">PMC5006495</ArticleId><ArticleId IdType="pubmed">27578023</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P, Rodriguez-Muela N, Klim JR, de Boer AS, Agrawal S, Sandoe J, Lopes CS, Ogliari KS, Williams LA, Shear M, et al. Reactive Astrocytes Promote ALS-like Degeneration and Intracellular Protein Aggregation in Human Motor Neurons by Disrupting Autophagy through TGF-beta1. Stem Cell Reports. 2017;9:667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P, Olivera-Bravo S, Trias E, Cragnolini A, Martinez-Palma L, Cassina P, Beckman J, Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz E, Izaurieta P, Weiss A, Mir FR, Rojas P, Gonzalez D, Rojas F, Brown RH, Jr, Madrid R, van Zundert B. Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J Neurophysiol. 2013;109:2803&#x2013;2814. doi: 10.1152/jn.00500.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00500.2012</ArticleId><ArticleId IdType="pmc">PMC3680799</ArticleId><ArticleId IdType="pubmed">23486205</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan J, da Costa NM, Cheadle L. Emerging roles of oligodendrocyte precursor cells in neural circuit development and remodeling. Trends Neurosci. 2023;46:628&#x2013;639. doi: 10.1016/j.tins.2023.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2023.05.007</ArticleId><ArticleId IdType="pmc">PMC10524797</ArticleId><ArticleId IdType="pubmed">37286422</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn S, Gritti L, Crooks D, Dombrowski Y. Oligodendrocytes in Development, Myelin Generation and Beyond. Cells. 2019;8(11):1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6912544</ArticleId><ArticleId IdType="pubmed">31726662</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasband MN, Peles E. Mechanisms of node of Ranvier assembly. Nat Rev Neurosci. 2021;22:7&#x2013;20. doi: 10.1038/s41583-020-00406-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-020-00406-8</ArticleId><ArticleId IdType="pubmed">33239761</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolind S, Sharma R, Knight S, Johansen-Berg H, Talbot K, Turner MR. Myelin imaging in amyotrophic and primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:562&#x2013;573. doi: 10.3109/21678421.2013.794843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.794843</ArticleId><ArticleId IdType="pmc">PMC3837681</ArticleId><ArticleId IdType="pubmed">23678852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Chung AY, Na JE, Lee SJ, Jeong SH, Kim E, Sun W, Rhyu IJ, Park HC. Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis. Glia. 2019;67:1910&#x2013;1921. doi: 10.1002/glia.23669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23669</ArticleId><ArticleId IdType="pubmed">31290185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons A, Higginbottom A, Cooper-Knock J, Alrafiah A, Alofi E, Kirby J, Shaw PJ, Wood JD, Highley JR. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J Pathol. 2020;251:262&#x2013;271. doi: 10.1002/path.5455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5455</ArticleId><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollink J, Hiemstra M, Miller KL, Huszar IN, Jenkinson M, Raaphorst J, Wiesmann M, Ansorge O, Pallebage-Gamarallage M. van Cappellen van Walsum AM: White matter changes in the perforant path area in patients with amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2019;45:570&#x2013;585. doi: 10.1111/nan.12555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12555</ArticleId><ArticleId IdType="pmc">PMC6852107</ArticleId><ArticleId IdType="pubmed">31002412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW, Rothstein JD, Bergles DE. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci. 2013;16:571&#x2013;579. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Traiffort E, Morisset-Lopez S, Moussaed M, Zahaf A. Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis. Int J Mol Sci. 2021;22(7):3426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8036314</ArticleId><ArticleId IdType="pubmed">33810425</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffaele S, Boccazzi M, Fumagalli M. Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives. Cells. 2021;10(3):565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8000560</ArticleId><ArticleId IdType="pubmed">33807572</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I, Rafalowska J, Fidzianska A, Gadamski R, Grieb P. Myelin composition of spinal cord in a model of amyotrophic lateral sclerosis (ALS) in SOD1G93A transgenic rats. Folia Neuropathol. 2007;45:236&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">18176898</ArticleId></ArticleIdList></Reference><Reference><Citation>Guipponi M, Li QX, Hyde L, Beissbarth T, Smyth GK, Masters CL, Scott HS. SAGE analysis of genes differentially expressed in presymptomatic TgSOD1G93A transgenic mice identified cellular processes involved in early stage of ALS pathology. J Mol Neurosci. 2010;41:172&#x2013;182. doi: 10.1007/s12031-009-9317-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-009-9317-1</ArticleId><ArticleId IdType="pubmed">19953340</ArticleId></ArticleIdList></Reference><Reference><Citation>Purger D, Gibson EM, Monje M. Myelin plasticity in the central nervous system. Neuropharmacology. 2016;110:563&#x2013;573. doi: 10.1016/j.neuropharm.2015.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.08.001</ArticleId><ArticleId IdType="pubmed">26282119</ArticleId></ArticleIdList></Reference><Reference><Citation>Arancibia-Carcamo IL, Ford MC, Cossell L, Ishida K, Tohyama K, Attwell D. Node of Ranvier length as a potential regulator of myelinated axon conduction speed. Elife. 2017;6:e23329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5313058</ArticleId><ArticleId IdType="pubmed">28130923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford MC, Alexandrova O, Cossell L, Stange-Marten A, Sinclair J, Kopp-Scheinpflug C, Pecka M, Attwell D, Grothe B. Tuning of Ranvier node and internode properties in myelinated axons to adjust action potential timing. Nat Commun. 2015;6:8073. doi: 10.1038/ncomms9073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9073</ArticleId><ArticleId IdType="pmc">PMC4560803</ArticleId><ArticleId IdType="pubmed">26305015</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman SA, Desmazieres A, Fricker D, Lubetzki C, Sol-Foulon N. Mechanisms of sodium channel clustering and its influence on axonal impulse conduction. Cell Mol Life Sci. 2016;73:723&#x2013;735. doi: 10.1007/s00018-015-2081-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-2081-1</ArticleId><ArticleId IdType="pmc">PMC4735253</ArticleId><ArticleId IdType="pubmed">26514731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada MS, Popovic MA, Kole MH. Loss of saltation and presynaptic action potential failure in demyelinated axons. Front Cell Neurosci. 2017;11:45. doi: 10.3389/fncel.2017.00045.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00045</ArticleId><ArticleId IdType="pmc">PMC5326753</ArticleId><ArticleId IdType="pubmed">28289377</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbluth J. Multiple functions of the paranodal junction of myelinated nerve fibers. J Neurosci Res. 2009;87:3250&#x2013;3258. doi: 10.1002/jnr.22013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22013</ArticleId><ArticleId IdType="pubmed">19224642</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldwell JH, Schaller KL, Lasher RS, Peles E, Levinson SR. Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses. Proc Natl Acad Sci U S A. 2000;97:5616&#x2013;5620. doi: 10.1073/pnas.090034797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.090034797</ArticleId><ArticleId IdType="pmc">PMC25877</ArticleId><ArticleId IdType="pubmed">10779552</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, Akiyama T, Warita H, Aoki M. Omics approach to axonal dysfunction of motor neurons in amyotrophic lateral sclerosis (ALS) Front Neurosci. 2020;14:194. doi: 10.3389/fnins.2020.00194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00194</ArticleId><ArticleId IdType="pmc">PMC7109447</ArticleId><ArticleId IdType="pubmed">32269505</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson VA, Mironova Y, Vanderpool KG, Waisman A, Rash JE, Agarwal A, Bergles DE. Oligodendrocytes control potassium accumulation in white matter and seizure susceptibility. Elife. 2018;7:e34829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5903864</ArticleId><ArticleId IdType="pubmed">29596047</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487:443&#x2013;448. doi: 10.1038/nature11314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11314</ArticleId><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Mobius W, et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485:517&#x2013;521. doi: 10.1038/nature11007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11007</ArticleId><ArticleId IdType="pmc">PMC3613737</ArticleId><ArticleId IdType="pubmed">22622581</ArticleId></ArticleIdList></Reference><Reference><Citation>Saab AS, Tzvetavona ID, Trevisiol A, Baltan S, Dibaj P, Kusch K, Mobius W, Goetze B, Jahn HM, Huang W, et al. Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron. 2016;91:119&#x2013;132. doi: 10.1016/j.neuron.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.05.016</ArticleId><ArticleId IdType="pmc">PMC9084537</ArticleId><ArticleId IdType="pubmed">27292539</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons M, Nave KA. Oligodendrocytes: Myelination and Axonal Support. Cold Spring Harb Perspect Biol. 2015;8:a020479. doi: 10.1101/cshperspect.a020479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020479</ArticleId><ArticleId IdType="pmc">PMC4691794</ArticleId><ArticleId IdType="pubmed">26101081</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18:225&#x2013;242. doi: 10.1038/nri.2017.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.125</ArticleId><ArticleId IdType="pubmed">29151590</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf SA, Boddeke HW, Kettenmann H. Microglia in Physiology and Disease. Annu Rev Physiol. 2017;79:619&#x2013;643. doi: 10.1146/annurev-physiol-022516-034406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-022516-034406</ArticleId><ArticleId IdType="pubmed">27959620</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8:752&#x2013;758. doi: 10.1038/nn1472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1472</ArticleId><ArticleId IdType="pubmed">15895084</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo UB, Wu LJ. Microglia: lifelong patrolling immune cells of the brain. Prog Neurobiol. 2019;179:101614. doi: 10.1016/j.pneurobio.2019.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6599472</ArticleId><ArticleId IdType="pubmed">31075285</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou LQ, Ma XT, Hu ZW, Yang S, Chen M, Bosco DB, Wu LJ, Tian DS. Dual functions of microglia in ischemic stroke. Neurosci Bull. 2019;35:921&#x2013;933. doi: 10.1007/s12264-019-00388-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-019-00388-3</ArticleId><ArticleId IdType="pmc">PMC6754485</ArticleId><ArticleId IdType="pubmed">31062335</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, Geser F, Lee VM, Grossman M, Trojanowski JQ. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol. 2012;123:395&#x2013;407. doi: 10.1007/s00401-011-0932-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0932-x</ArticleId><ArticleId IdType="pmc">PMC3595560</ArticleId><ArticleId IdType="pubmed">22210083</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, Aijo T, Vickovic S, Braine C, Kang K, Mollbrink A, Fagegaltier D, Andrusivova Z, Saarenpaa S, Saiz-Castro G, et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, Propp N, Consortium NA. Fagegaltier D, Harris BT, et al. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep. 2019;29:1164&#x2013;1177. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke BE, Patani R. The microglial component of amyotrophic lateral sclerosis. Brain. 2020;143:3526&#x2013;3539. doi: 10.1093/brain/awaa309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa309</ArticleId><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, Canter RG, Roberts CJ, Miller KR, Ransohoff RM, Trojanowski JQ, Lee VM. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Brites D, Vaz AR. Microglia centered pathogenesis in ALS: insights in cell interconnectivity. Front Cell Neurosci. 2014;8:117. doi: 10.3389/fncel.2014.00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00117</ArticleId><ArticleId IdType="pmc">PMC4033073</ArticleId><ArticleId IdType="pubmed">24904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Zhao W, Appel SH. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol. 2009;4:389&#x2013;398. doi: 10.1007/s11481-009-9171-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId><ArticleId IdType="pubmed">19731042</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie M, Zhao S, Bosco DB, Nguyen A, Wu LJ. Microglial TREM2 in amyotrophic lateral sclerosis. Dev Neurobiol. 2022;82:125&#x2013;137. doi: 10.1002/dneu.22864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.22864</ArticleId><ArticleId IdType="pmc">PMC8898078</ArticleId><ArticleId IdType="pubmed">34874625</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D'Ambrosi N. The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches. Front Aging Neurosci. 2017;9:242. doi: 10.3389/fnagi.2017.00242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargsyan SA, Monk PN, Shaw PJ. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia. 2005;51:241&#x2013;253. doi: 10.1002/glia.20210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20210</ArticleId><ArticleId IdType="pubmed">15846792</ArticleId></ArticleIdList></Reference><Reference><Citation>Isbrandt D. A mechanistic link between glia and neuronal excitability in acute neuroinflammation. J Physiol. 2017;595:603&#x2013;604. doi: 10.1113/JP273252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP273252</ArticleId><ArticleId IdType="pmc">PMC5285621</ArticleId><ArticleId IdType="pubmed">28145018</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7:31&#x2013;40. doi: 10.1038/nrneurol.2010.178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.178</ArticleId><ArticleId IdType="pmc">PMC3378051</ArticleId><ArticleId IdType="pubmed">21135885</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K, Thammisetty SS, Boutej H, Bareil C, Julien JP. Mitigation of ALS pathology by neuron-specific inhibition of nuclear factor kappa B signaling. J Neurosci. 2020;40:5137&#x2013;5154. doi: 10.1523/JNEUROSCI.0536-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0536-20.2020</ArticleId><ArticleId IdType="pmc">PMC7314413</ArticleId><ArticleId IdType="pubmed">32457070</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, Ladner KJ, Bevan AK, Foust KD, Godbout JP, et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci U S A. 2012;109:E197&#x2013;205. doi: 10.1073/pnas.1111098109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1111098109</ArticleId><ArticleId IdType="pmc">PMC3268269</ArticleId><ArticleId IdType="pubmed">22167804</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Lennon VA, Liu YU, Bosco DB, Li Y, Yi MH, Zhu J, Wei S, Wu LJ. Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion. J Clin Invest. 2020;130:4025&#x2013;4038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410082</ArticleId><ArticleId IdType="pubmed">32568214</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Liu Y, Umpierre AD, Xie M, Tian DS, Richardson JR, Wu LJ. Microglial P2Y12 receptor regulates ventral hippocampal CA1 neuronal excitability and innate fear in mice. Mol Brain. 2019;12:71. doi: 10.1186/s13041-019-0492-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0492-x</ArticleId><ArticleId IdType="pmc">PMC6700820</ArticleId><ArticleId IdType="pubmed">31426845</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierre AD, Wu LJ. How microglia sense and regulate neuronal activity. Glia. 2021;69:1637&#x2013;1653. doi: 10.1002/glia.23961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23961</ArticleId><ArticleId IdType="pmc">PMC8113084</ArticleId><ArticleId IdType="pubmed">33369790</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo UB, Peng J, Swiatkowski P, Mukherjee A, Bispo A, Wu LJ. Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus. J Neurosci. 2014;34:10528&#x2013;10540. doi: 10.1523/JNEUROSCI.0416-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0416-14.2014</ArticleId><ArticleId IdType="pmc">PMC4200107</ArticleId><ArticleId IdType="pubmed">25100587</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu N, Eyo UB, Murugan M, Peng J, Matta S, Dong H, Wu LJ. Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain. Brain Behav Immun. 2016;55:82&#x2013;92. doi: 10.1016/j.bbi.2015.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.11.007</ArticleId><ArticleId IdType="pmc">PMC4864135</ArticleId><ArticleId IdType="pubmed">26576724</ArticleId></ArticleIdList></Reference><Reference><Citation>Cieslak M, Roszek K, Wujak M. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives. Purinergic Signal. 2019;15:1&#x2013;15. doi: 10.1007/s11302-018-9633-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-018-9633-4</ArticleId><ArticleId IdType="pmc">PMC6439052</ArticleId><ArticleId IdType="pubmed">30430356</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Hall B, Castelli LM, Francis L, Woof R, Siskos AP, Kouloura E, Gray E, Thompson AG, Talbot K, et al. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain. 2019;142:586&#x2013;605. doi: 10.1093/brain/awy353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy353</ArticleId><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandelman M, Peluffo H, Beckman JS, Cassina P, Barbeito L. Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. J Neuroinflammation. 2010;7:33. doi: 10.1186/1742-2094-7-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-33</ArticleId><ArticleId IdType="pmc">PMC2901222</ArticleId><ArticleId IdType="pubmed">20534165</ArticleId></ArticleIdList></Reference><Reference><Citation>Laprell L, Schulze C, Brehme ML, Oertner TG. The role of microglia membrane potential in chemotaxis. J Neuroinflammation. 2021;18:21. doi: 10.1186/s12974-020-02048-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02048-0</ArticleId><ArticleId IdType="pmc">PMC7798195</ArticleId><ArticleId IdType="pubmed">33423699</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi MH, Liu YU, Umpierre AD, Chen T, Ying Y, Zheng J, Dheer A, Bosco DB, Dong H, Wu LJ. Optogenetic activation of spinal microglia triggers chronic pain in mice. PLoS Biol. 2021;19:e3001154. doi: 10.1371/journal.pbio.3001154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001154</ArticleId><ArticleId IdType="pmc">PMC8011727</ArticleId><ArticleId IdType="pubmed">33739978</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierre AD, Bystrom LL, Ying Y, Liu YU, Worrell G, Wu LJ. Microglial calcium signaling is attuned to neuronal activity in awake mice. Elife. 2020;9:e56502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402678</ArticleId><ArticleId IdType="pubmed">32716294</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli RC, Bisht K, Tremblay ME. Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front Cell Neurosci. 2014;8:129. doi: 10.3389/fncel.2014.00129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00129</ArticleId><ArticleId IdType="pmc">PMC4026677</ArticleId><ArticleId IdType="pubmed">24860431</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawelec P, Ziemka-Nalecz M, Sypecka J, Zalewska T. The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders. Cells. 2020;9(10):2277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600611</ArticleId><ArticleId IdType="pubmed">33065974</ArticleId></ArticleIdList></Reference><Reference><Citation>Albertini G, Etienne F, Roumier A. Regulation of microglia by neuromodulators: Modulations in major and minor modes. Neurosci Lett. 2020;733:135000. doi: 10.1016/j.neulet.2020.135000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.135000</ArticleId><ArticleId IdType="pubmed">32344106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabel MK, Kirsch WM. From development to dysfunction: microglia and the complement cascade in CNS homeostasis. Ageing Res Rev. 2013;12:749&#x2013;756. doi: 10.1016/j.arr.2013.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2013.02.001</ArticleId><ArticleId IdType="pmc">PMC3700678</ArticleId><ArticleId IdType="pubmed">23419464</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712&#x2013;716. doi: 10.1126/science.aad8373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8373</ArticleId><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D, Lorenzini I, Mota TA, Bell S, Mahan TE, Ulrich JD, Davtyan H, Rexach JE, Muhammad A, Shelest O, et al. C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation. Neuron. 2021;109(14):2275&#x2013;2291.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298293</ArticleId><ArticleId IdType="pubmed">34133945</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456&#x2013;1458. doi: 10.1126/science.1202529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1202529</ArticleId><ArticleId IdType="pubmed">21778362</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, Erreni M, Markicevic M, Starvaggi-Cucuzza C, Otero K, et al. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity. 2018;48:979&#x2013;991. doi: 10.1016/j.immuni.2018.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.04.016</ArticleId><ArticleId IdType="pubmed">29752066</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott-Hewitt N, Perrucci F, Morini R, Erreni M, Mahoney M, Witkowska A, Carey A, Faggiani E, Schuetz LT, Mason S, et al. Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia. EMBO J. 2020;39:e105380. doi: 10.15252/embj.2020105380.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020105380</ArticleId><ArticleId IdType="pmc">PMC7429741</ArticleId><ArticleId IdType="pubmed">32657463</ArticleId></ArticleIdList></Reference><Reference><Citation>Cserep C, Posfai B, Lenart N, Fekete R, Laszlo ZI, Lele Z, Orsolits B, Molnar G, Heindl S, Schwarcz AD, et al. Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science. 2020;367:528&#x2013;537. doi: 10.1126/science.aax6752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax6752</ArticleId><ArticleId IdType="pubmed">31831638</ArticleId></ArticleIdList></Reference><Reference><Citation>Benusa SD, Lafrenaye AD. Microglial process convergence on axonal segments in health and disease. Neuroimmunol Neuroinflamm. 2020;7:23&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8128155</ArticleId><ArticleId IdType="pubmed">34007863</ArticleId></ArticleIdList></Reference><Reference><Citation>Baalman K, Marin MA, Ho TS, Godoy M, Cherian L, Robertson C, Rasband MN. Axon initial segment-associated microglia. J Neurosci. 2015;35:2283&#x2013;2292. doi: 10.1523/JNEUROSCI.3751-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3751-14.2015</ArticleId><ArticleId IdType="pmc">PMC4315845</ArticleId><ArticleId IdType="pubmed">25653382</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronzano R, Roux T, Thetiot M, Aigrot MS, Richard L, Lejeune FX, Mazuir E, Vallat JM, Lubetzki C, Desmazieres A. Microglia-neuron interaction at nodes of Ranvier depends on neuronal activity through potassium release and contributes to remyelination. Nat Commun. 2021;12:5219. doi: 10.1038/s41467-021-25486-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25486-7</ArticleId><ArticleId IdType="pmc">PMC8410814</ArticleId><ArticleId IdType="pubmed">34471138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato G, Inada H, Wake H, Akiyoshi R, Miyamoto A, Eto K, Ishikawa T, Moorhouse AJ, Strassman AM, Nabekura J. Microglial Contact Prevents Excess Depolarization and Rescues Neurons from Excitotoxicity. eNeuro. 2016;3(3):ENEURO.0004&#x2013;16.2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4916329</ArticleId><ArticleId IdType="pubmed">27390772</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo NB, Berisha A, Van Aelst L. Microglia regulate chandelier cell axo-axonic synaptogenesis. Proc Natl Acad Sci U S A. 2022;119:e2114476119. doi: 10.1073/pnas.2114476119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2114476119</ArticleId><ArticleId IdType="pmc">PMC8931231</ArticleId><ArticleId IdType="pubmed">35263225</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras D. Electrophysiological classes of neocortical neurons. Neural Netw. 2004;17:633&#x2013;646. doi: 10.1016/j.neunet.2004.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neunet.2004.04.003</ArticleId><ArticleId IdType="pubmed">15288889</ArticleId></ArticleIdList></Reference><Reference><Citation>Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, Hwang P, Chan AT, Graves SM, Uweru JO, et al. Negative feedback control of neuronal activity by microglia. Nature. 2020;586:417&#x2013;423. doi: 10.1038/s41586-020-2777-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2777-8</ArticleId><ArticleId IdType="pmc">PMC7577179</ArticleId><ArticleId IdType="pubmed">32999463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Li Y, Wei Y, Bosco DB, Xie M, Zhao MG, Richardson JR, Wu LJ. Microglial depletion aggravates the severity of acute and chronic seizures in mice. Brain Behav Immun. 2020;89:245&#x2013;255. doi: 10.1016/j.bbi.2020.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.028</ArticleId><ArticleId IdType="pmc">PMC7572576</ArticleId><ArticleId IdType="pubmed">32621847</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandereyken K, Sifrim A, Thienpont B, Voet T. Methods and applications for single-cell and spatial multi-omics. Nat Rev Genet. 2023;24:494&#x2013;515. doi: 10.1038/s41576-023-00580-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-023-00580-2</ArticleId><ArticleId IdType="pmc">PMC9979144</ArticleId><ArticleId IdType="pubmed">36864178</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum JA, Gitler AD. Singling out motor neurons in the age of single-cell transcriptomics. Trends Genet. 2022;38:904&#x2013;919. doi: 10.1016/j.tig.2022.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC9378604</ArticleId><ArticleId IdType="pubmed">35487823</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineda SS, Lee H, Fitzwalter BE, Mohammadi S, Pregent LJ, Gardashli ME, Mantero J, Engelberg-Cook E, DeJesus-Hernandez M, Blitterswijk Mv, et al: Single-cell profiling of the human primary motor cortex in ALS and FTLD. bioRxiv 2021:2021.2007.2007.451374.</Citation></Reference><Reference><Citation>Hasan R, Humphrey J, Bettencourt C, Consortium NA, Lashley T, Fratta P, Raj T: Transcriptomic analysis of frontotemporal lobar degeneration with TDP-43 pathology reveals cellular alterations across multiple brain regions. medRxiv 2021:2021.2010.2006.21264635.</Citation><ArticleIdList><ArticleId IdType="pubmed">34961893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JC, Ramaswami G, Geschwind DH. Gene co-expression network analysis in human spinal cord highlights mechanisms underlying amyotrophic lateral sclerosis susceptibility. Sci Rep. 2021;11:5748. doi: 10.1038/s41598-021-85061-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85061-4</ArticleId><ArticleId IdType="pmc">PMC7970949</ArticleId><ArticleId IdType="pubmed">33707641</ArticleId></ArticleIdList></Reference><Reference><Citation>Szebenyi K, Wenger LMD, Sun Y, Dunn AWE, Limegrover CA, Gibbons GM, Conci E, Paulsen O, Mierau SB, Balmus G, Lakatos A. Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nat Neurosci. 2021;24:1542&#x2013;1554. doi: 10.1038/s41593-021-00923-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00923-4</ArticleId><ArticleId IdType="pmc">PMC8553627</ArticleId><ArticleId IdType="pubmed">34675437</ArticleId></ArticleIdList></Reference><Reference><Citation>Namboori SC, Thomas P, Ames R, Hawkins S, Garrett LO, Willis CRG, Rosa A, Stanton LW, Bhinge A. Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons. Stem Cell Reports. 2021;16:3020&#x2013;3035. doi: 10.1016/j.stemcr.2021.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.10.010</ArticleId><ArticleId IdType="pmc">PMC8693652</ArticleId><ArticleId IdType="pubmed">34767750</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Beltran LC, Godoy-Corchuelo JM, Losa-Fontangordo M, Williams D, Matias-Guiu J, Corrochano S. A transcriptomic meta-analysis shows lipid metabolism dysregulation as an early pathological mechanism in the spinal cord of SOD1 mice. Int J Mol Sci. 2021;22(17):9553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8431303</ArticleId><ArticleId IdType="pubmed">34502460</ArticleId></ArticleIdList></Reference><Reference><Citation>Guise AJ, Misal SA, Carson R, Boekweg H, Van Der Watt D, Truong T, Liang Y, Chu JH, Welsh NC, Gagnon J, et al: TDP-43-stratified single-cell proteomic profiling of postmortem human spinal motor neurons reveals protein dynamics in amyotrophic lateral sclerosis. bioRxiv 2023.</Citation></Reference><Reference><Citation>Wang HV, Veire AM, Gendron TF, Gearing M, Glass JD, Jin P, Corces VG, McEachin ZT: Single nucleus multiome analysis of the prefrontal cortex from C9orf72 ALS/FTD patients illuminates pathways affected during disease progression. bioRxiv 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>